Quest Diagnostics (DGX) Operating Leases: 2019-2025
Historic Operating Leases for Quest Diagnostics (DGX) over the last 7 years, with Sep 2025 value amounting to $534.0 million.
- Quest Diagnostics' Operating Leases fell 1.66% to $534.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $534.0 million, marking a year-over-year decrease of 1.66%. This contributed to the annual value of $535.0 million for FY2024, which is 19.31% down from last year.
- As of Q3 2025, Quest Diagnostics' Operating Leases stood at $534.0 million, which was down 1.11% from $540.0 million recorded in Q2 2025.
- In the past 5 years, Quest Diagnostics' Operating Leases ranged from a high of $679.0 million in Q4 2021 and a low of $489.0 million during Q1 2024.
- Over the past 3 years, Quest Diagnostics' median Operating Leases value was $534.0 million (recorded in 2025), while the average stood at $532.0 million.
- Per our database at Business Quant, Quest Diagnostics' Operating Leases increased by 22.98% in 2021 and then decreased by 19.31% in 2024.
- Over the past 5 years, Quest Diagnostics' Operating Leases (Quarterly) stood at $679.0 million in 2021, then fell by 4.12% to $651.0 million in 2022, then rose by 1.84% to $663.0 million in 2023, then fell by 19.31% to $535.0 million in 2024, then dropped by 1.66% to $534.0 million in 2025.
- Its last three reported values are $534.0 million in Q3 2025, $540.0 million for Q2 2025, and $538.0 million during Q1 2025.